AnuBio
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at AnuBio
Adrian Grzybowski
Chief Science Officer, Co-founder
AnuBio Email Formats
AnuBio uses 2 email formats. The most common is {first initial} (e.g., j@anubio.ai), used 60% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@anubio.ai | 60% |
{first name} | john@anubio.ai | 40% |
About AnuBio
We are a team of interdisciplinary scientists united by the common goal of finding novel and effective immunotherapies that outperform current standard of care for lung and skin cancer. Our diverse and combined experience allows us to embrace and tie together the robustness of recent scientific advances in tech-bio and the resilience of conventional drug development strategies. At AnuBio, we focus on closed-loop lab-AI drug discovery to reprogram immune responses by mapping the higher-order immune interactions. Our foundational model is also designed to derisk drug development by reliably predicting human clinical performance characteristics of lead candidates. Visit our website: https://anubio.ai/ We’d be delighted to address your questions and explore potential partnerships. Please contact us at: press@anubio.ai.
AnuBio revenue & valuation
| Annual revenue | $427,775 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,400,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
AnuBio has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
AnuBio has never raised funding before.
Canada
Frequently asked questions
4.8
40,000 users
